HDV Screening Study
ConditionHepatitis D Virus Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGrace Lai Hung Wong
About this trial
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
Eligibility criteria
Qualifiers
Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND
Aged 18 years old or above.
Written or verbal consent obtained
Disqualifiers
Refusal to consent
Age < 18 years
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Grace Lai Hung Wong
Lead sponsor
Chinese University of Hong Kong
Sponsor institution
Gilead Sciences
Collaborator
Source ClinicalTrials.gov